Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2022 Aug;20(4):808-809.
doi: 10.1016/j.gpb.2022.12.009.

Corrigendum to "An Integrated Systems Biology Approach Identifies the Proteasome as A Critical Host Machinery for ZIKV and DENV Replication" [Genomics Proteomics Bioinformatics19 (1) (2021) 108-122]

Affiliations
Published Erratum

Corrigendum to "An Integrated Systems Biology Approach Identifies the Proteasome as A Critical Host Machinery for ZIKV and DENV Replication" [Genomics Proteomics Bioinformatics19 (1) (2021) 108-122]

Guang Song et al. Genomics Proteomics Bioinformatics. 2022 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 6
Figure 6
Experimental validation of the proteasome inhibitors A. PPI network analysis of virus proteins and human proteasome subunits reveals that most of the interacting proteasome subunits are part of the 20S core particle. B. Percentage of the ZIKV-binding subunits in 26S proteasome and its two sub-complexes, the 20S core particle and the 19S regulatory particle. C. Inhibition of ZIKV expression in human glioblastoma cell line SNB-19 by a panel of proteasome inhibitors. The SNB-19 cells were infected by ZIKV PRVABC59 (MOI = 1) in the presence of 1 µM of each inhibitor and then incubated for 48 h before the cultures were analyzed for ZIKV-E protein expression by immunostaining. Mock indicates cells without ZIKV infection. Scale bar: 100 µm. D. and E. Sample images (D) and quantification (E) of titer assay to assess the potency of the proteasome inhibitors against infectious ZIKV production in SNB-19 cells. All data were normalized to that of 0 µM for each compound. Dose-dependent antiviral activity is presented as fluorescent focus-forming units per ml (FFU/ml) and data are represented as mean ± SD (n = 6). Curves represent best fits for calculating IC50 values (listed to the right). MOI, multiplicity of infection; ZIKV-E, ZIKV envelope.

Erratum for

Publication types